Ren Qin, Hua Ling, Zhou Xiaofang, Cheng Yong, Lu Mingjun, Zhang Chuanqing, Guo Jianrong, Xu Hua
Department of Anesthesiology, Shanghai Pudong New Area Gongli Hospital, Navy Military Medical University, Shanghai, China.
Department of Laboratory Medicine, Shanghai Pudong New Area Gongli Hospital, Navy Military Medical University, Shanghai, China.
Front Pharmacol. 2022 Apr 5;13:818822. doi: 10.3389/fphar.2022.818822. eCollection 2022.
To investigate the effect of a single sub-anesthetic dose of ketamine on postoperative anxiety, depression, and inflammatory factors in patients with colorectal cancer. A total of 104 patients undergoing selective colorectal surgery in our hospital from Jan 2015 to Oct 2017 were included and randomly assigned (1:1:1:1) into a 0.1 mg kg ketamine group (K1 group), 0.2 mg kg ketamine group (K2 group), 0.3 mg kg ketamine group (K3 group), or control group (C group). Corresponding doses of ketamine were given intravenously in the K groups (K1, K2, and K3 groups) 5 min before operation, and the same amount of normal saline was given in the C group. The intravenous analgesia program was identical in the four groups. The patients' emotional reactions (anxiety and depression) were assessed by the Hospital Anxiety and Depression Scale (HAD), the quality of postoperative recovery was evaluated by the Quality of Recovery-40 (QoR-40) questionnaire, and the levels of IL-6, IL-8, and TNF-α in peripheral blood were detected by enzyme-linked immunosorbent assay (ELISA) on the day before operation and within 24, 48, and 72 h post-operation respectively. Pain was estimated by the visual analog scale (VAS), and sedation was assessed with Ramsay score 30 min after extubation. The time points of anesthetic end and extubation were recorded. The complications during anesthesia and recovery such as cough and agitation 30 min after extubation were recorded. The anxiety score (HAD-A) and depression score (HAD-D) of the K3 group were significantly lower than those of the C group post-operation ( < 0.05). The QoR-40 score of the K3 group was significantly higher than that of the C group ( < 0.05). The serum levels of IL-6, IL-8, and TNF-α in the K3 group were significantly lower than those in the C group ( < 0.05 and < 0.01). There were no significant differences in HAD-A, HAD-D, and QoR-40 scores or serum levels of IL-6, IL-8, and TNF-α between the K1 and K2 groups and the C group. There were no significant differences in VAS pain score or Ramsay sedation score among the four groups 30 min after extubation. There were no significant differences in extubation time, postoperative cough, emergence agitation, or delirium among the four groups. Dizziness, nausea, vomiting, diplopia, or other adverse reactions were not found 30 min after extubation. A single sub-anesthetic dose (0.3 mg kg) of ketamine can significantly improve the postoperative anxiety and depression of colorectal cancer patients and reduce the levels of IL-6, IL-8, and TNF-α.
探讨单次亚麻醉剂量氯胺酮对结直肠癌患者术后焦虑、抑郁及炎症因子的影响。纳入2015年1月至2017年10月在我院接受择期结直肠手术的104例患者,并将其随机分为(1:1:1:1)0.1mg/kg氯胺酮组(K1组)、0.2mg/kg氯胺酮组(K2组)、0.3mg/kg氯胺酮组(K3组)或对照组(C组)。K组(K1、K2和K3组)在手术前5分钟静脉注射相应剂量的氯胺酮,C组静脉注射等量的生理盐水。四组的静脉镇痛方案相同。采用医院焦虑抑郁量表(HAD)评估患者的情绪反应(焦虑和抑郁),采用术后恢复质量-40(QoR-40)问卷评估术后恢复质量,分别于手术前一天及术后24、48和72小时采用酶联免疫吸附测定(ELISA)法检测外周血中IL-6、IL-8和TNF-α的水平。采用视觉模拟评分法(VAS)评估疼痛程度,拔管后30分钟采用Ramsay评分评估镇静程度。记录麻醉结束和拔管时间点。记录麻醉及恢复过程中的并发症,如拔管后30分钟的咳嗽和躁动。术后K3组的焦虑评分(HAD-A)和抑郁评分(HAD-D)显著低于C组(<0.05)。K3组的QoR-40评分显著高于C组(<0.05)。K3组血清IL-6、IL-8和TNF-α水平显著低于C组(<0.05和<0.01)。K1组和K2组与C组在HAD-A、HAD-D和QoR-40评分或血清IL-6、IL-8和TNF-α水平方面无显著差异。拔管后30分钟,四组间VAS疼痛评分或Ramsay镇静评分无显著差异。四组在拔管时间、术后咳嗽、苏醒期躁动或谵妄方面无显著差异。拔管后30分钟未发现头晕、恶心、呕吐、复视或其他不良反应。单次亚麻醉剂量(0.3mg/kg)氯胺酮可显著改善结直肠癌患者术后的焦虑和抑郁,并降低IL-6、IL-8和TNF-α水平。